Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. (Q39704543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

4

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Peter A Prieto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Katherine H Durflinger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

John R Wunderlich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Mark E Dudley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Journal of Immunotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

547-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

2 February 2020

cites work

1 reference

12 December 2020

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

1 reference

12 December 2020

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

12 December 2020

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

12 December 2020

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

12 December 2020

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

12 December 2020

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions

1 reference

12 December 2020

Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples

1 reference

12 December 2020

Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells

1 reference

12 December 2020

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

1 reference

12 December 2020

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)

1 reference

12 December 2020

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion

1 reference

12 December 2020

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

1 reference

12 December 2020

Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy

1 reference

12 December 2020

Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells

1 reference

12 December 2020

Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.

1 reference

12 December 2020

Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review

1 reference

12 December 2020

Management of metastatic melanoma

1 reference

12 December 2020

Tumor-specific Th17-polarized cells eradicate large established melanoma

1 reference

12 December 2020

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

12 December 2020

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

1 reference

12 December 2020

Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines

1 reference

12 December 2020

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

1 reference

12 December 2020

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

12 December 2020

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

1 reference

12 December 2020

1 reference

12 December 2020

Ipilimumab: controversies in its development, utility and autoimmune adverse events

1 reference

12 December 2020

Adoptive cell therapy for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

1 reference

12 December 2020

Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer

1 reference

12 December 2020

Predicting and controlling the reactivity of immune cell populations against cancer

1 reference

12 December 2020

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

1 reference

12 December 2020

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease

1 reference

12 December 2020

10.1097/CJI.0B013E3181D367BD

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20463593%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

PubMed publication ID

20463593

1 reference